重庆医学2017，Vol.46Issue(23)：3173-3176,4.DOI:10.3969/j.issn.1671-8348.2017.23.002
放射性碘化氟维司群对激素依赖性人乳腺癌治疗作用研究
The growth inhibition effect of 131I-fulvestrant on the human breast cancer cells
摘要
Abstract
Objective To elucidate the inhibitory effect of 131I-fulvestrant on the growth of human breast cancer cells and the effect on the important organs.Methods MTT assay was used to clarify the difference in killing effects of the 131I-fulvestranton on MCF-7 cells and MDA-MB-231 cells.Breast cancer MCF-7 cell xenografts in nude mice was establishied,and two different administration methods of the 131I-fulvestrant in the MCF-7 cell to nude mice were given respectively.Organs and tumours of nude mice were observed.Results MTT assay demonstrated that 131I-fulvestrant had similar cytotoxicity against MCF-7 cells and MDA-MB-231 cells,and the former was slightly stronger.Transient contact experiments showed that 131I-fulvestrant could play a tumor suppressor effect on MCF-7 cells continually,but MDA-MB-231 cells wasn't.After the injection of 131I-fulvestrant via caudal vein,the radioactivity concentration on tumor site accounted for (4.33 ± 0.28)％ of the total injection,and the volume of the tumor reduced before gradually increasing again.Radioactivity in the blood accounted for (20.76 ± 2.54)％ of the total injection.Qrgans like liver and kidney also showed radioaction distribution.Its distribution was accorded with the distribution of estrogen receptor.Local injection of 131I-fulvestrant got powerful killing effect on the tumor,and the distribution of the radioaction was mainly confined within the tumor.Conclusion 131I-fulvestrant has a good inhibitory effect on MCF-7 breast cancer cells,which is a superposition of radiotherapy and endocrine therapy,and it is controllable on the general condition and important organs of nude mice.关键词
碘化氟维司群/乳腺肿瘤/MCF-7/MDA-MB-23/肿瘤移植/生长抑制Key words
131I-fulvestrant/breast neoplasms/MCF-7/MDA-MB-23/neoplasm transplantation/growth inhibition分类
医药卫生引用本文复制引用
印国兵,曾斌,刘瑛,孙璐..放射性碘化氟维司群对激素依赖性人乳腺癌治疗作用研究[J].重庆医学,2017,46(23):3173-3176,4.基金项目
重庆市自然科学基金资助项目(cstc2012jjA10042) （cstc2012jjA10042）
重庆市卫生局科研基金资助项目(2011-2-175). （2011-2-175）
